AT2 receptors targeting cardiac protection post-myocardial infarction
E Kaschina, D Lauer, P Schmerler, T Unger… - Current hypertension …, 2014 - Springer
The angiotensin AT2-receptor mediates tissue protective actions. Its regenerative potential
has been tested in multiple disease models including models of myocardial infarction. These …
has been tested in multiple disease models including models of myocardial infarction. These …
Enhanced angiotensin II activity in heart failure: reevaluation of the counterregulatory hypothesis of receptor subtypes
LH Opie, MN Sack - Circulation research, 2001 - Am Heart Assoc
There are strong data favoring the pathogenic role of angiotensin II type 1 receptor (AT1)
activation with subsequent promotion of myocyte growth and cardiac fibrosis in the …
activation with subsequent promotion of myocyte growth and cardiac fibrosis in the …
Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts
J Bartunek, EO Weinberg, M Tajima, S Rohrbach… - Circulation, 1999 - Am Heart Assoc
Background—We have previously shown that the acute molecular growth response of new
protein synthesis and protein kinase C activation in response to angiotensin II (Ang II) is …
protein synthesis and protein kinase C activation in response to angiotensin II (Ang II) is …
Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction
JFX Ainscough, MJ Drinkhill, A Sedo… - Cardiovascular …, 2009 - academic.oup.com
Aims Sustained hypertension leads to cardiac hypertrophy that can progress, through
pathological remodelling, to heart failure. Abnormality of the renin–angiotensin system …
pathological remodelling, to heart failure. Abnormality of the renin–angiotensin system …
Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy
Left ventricular hypertrophy (LVH) is considered to be an independent risk factor giving rise
to ischemia, arrhythmia, and left ventricular dysfunction. In this article, we summarize recent …
to ischemia, arrhythmia, and left ventricular dysfunction. In this article, we summarize recent …
[HTML][HTML] Angiotensin AT2 receptors: cardiovascular hope or hype?
RE Widdop, ES Jones, RE Hannan… - British journal of …, 2003 - ncbi.nlm.nih.gov
It is widely accepted that the angiotensin II type 1 receptor (AT1R) accounts for the majority
of cardiovascular effects evoked by angiotensin II (Ang II), such as contraction/pressor …
of cardiovascular effects evoked by angiotensin II (Ang II), such as contraction/pressor …
The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous
TL Reudelhuber - Hypertension, 2005 - Am Heart Assoc
Left ventricular hypertrophy (LVH) associated with hy-pertension puts patients at heightened
risk for further cardiovascular complications. There has been lot of interest in the effects of …
risk for further cardiovascular complications. There has been lot of interest in the effects of …
Alterations of angiotensin II receptor contents in hypertrophied hearts
N Fujii, M Tanaka, J Ohnishi, K Yukawa… - Biochemical and …, 1995 - Elsevier
Tsukuba hypertensive mice, which carry the human genes for renin and angiotensinogen,
show cardiac hypertrophy as well as hypertension due to activation of the renin-angiotensin …
show cardiac hypertrophy as well as hypertension due to activation of the renin-angiotensin …
[HTML][HTML] Angiotensin II type-2 receptor-specific effects on the cardiovascular system
Y Li, X Li, H Yuan - Cardiovascular diagnosis and therapy, 2012 - ncbi.nlm.nih.gov
The renin-angiotensin system (RAS) is intricately involved in cardiovascular homeostasis. It
is well known that angiotensin II, the key effector in RAS, contributes to a range of …
is well known that angiotensin II, the key effector in RAS, contributes to a range of …
Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
H Masaki, T Kurihara, A Yamaki… - The Journal of …, 1998 - Am Soc Clin Investig
Angiotensin (Ang) II has two major receptor isoforms, AT1 and AT2. Currently, AT1
antagonists are undergoing clinical trials in patients with cardiovascular diseases. Treatment …
antagonists are undergoing clinical trials in patients with cardiovascular diseases. Treatment …